Viewpoint News & Awards

Viewpoint research published in Molecular Pharmaceutics

July 18th, 2019 – Iowa City, Iowa, Viewpoint and collaborators from the University of Iowa and the University of Missouri received have received acceptance notification for their manuscript titled “Enhancing the efficacy of melanocortin 1 receptor-targeted radiotherapy by pharmacologically upregulating the receptor in metastatic melanoma” from peer reviewed journal Molecular Pharmaceutics. The authors of this manuscript are: Li, Mengshi; Liu, Dijie; Lee, Dongyoul; Kapoor, Somya; Gibson-Corley, Katherine; Quinn, Thomas; Sagastume, Edwin; Mott, Sarah; Walsh, Susan; Acevedo, Michael; Johnson, Frances; Schultz, Michael. The publication can be found by searching this information. Journal: Molecular Pharmaceutics 31 Jul (Manuscript ID: mp-2019-00512p.R1.) 

Web access: https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.9b00512